Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The company's stock has fallen 41% since closing at $66 per share on Thursday after the Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply
Applications in Research As a molecular probe for studying neuropeptide-mediated signalling in central nervous system models Investigation of peptide interactions within neuroendocrine and stress-related pathways In vitro studies examining peptide stability, degradation, and carrier-protein interactions As a reference compound in research involving short endogenous neuropeptides Handling, Reconstitution & Stability Weigh under dry conditions
Insurers must decide how to categorize each drug
The worst thing you can do is to slow the ball or worse, stopping it from getting where you want it to get
US$ 29.33
US$ 21.88
US$ 22.75
